The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy

Table 1

Frequency distribution (number and percent) of demographic and clinical characteristics among radical prostatectomy patients (𝑛=383).

Characteristic	All men		Recurrence		No recurrence
	𝑁	%	𝑁	%	𝑁	%
Age*	60.9	10.1	60.6	5.9	60.9	6.8
Race
Caucasian	215	56.1	38	56.7	177	56.0
African American	168	43.9	29	43.3	139	44.0
Smoking history
Ever	249	65.0	51	76.1	198	62.7
Never	134	35.0	16	23.9	118	37.3
Pretreatment PSA (ng/ml)
≤10	331	86.4	50	74.6	281	88.9
>10	52	13.6	17	20.4	35	11.1
Gleason score
≤7 (3+4)	280	73.1	41	61.2	239	75.6
≥7 (4+3)	103	26.9	26	38.8	77	24.4
Stage
Local	321	83.8	49	73.1	272	86.1
Regional	58	15.2	15	22.4	43	13.6
Distant	4	1.0	3	4.5	1	0.3
Surgical margin status
Positive	111	29.8	38	56.7	73	23.1
Negative	262	70.2	27	43.3	235	76.9

*Mean value with standard deviation.